U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
147541147541A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing HomesCompletedNo Results AvailableAlzheimer DiseaseDrug: Donepezil (Aricept)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00630851
147542147542Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)CompletedNo Results AvailableHirschsprung DiseaseDrug: VSL#3|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00630838
147543147543A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes MellitusCompletedHas ResultsDiabetes Mellitus Type 2Drug: LY2189265|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00630825
147544147544Long Term Administration of Inhaled Mannitol in Cystic FibrosisCompletedNo Results AvailableCystic FibrosisDrug: inhaled mannitol|Drug: Placebo comparatorhttps://ClinicalTrials.gov/show/NCT00630812
147545147545Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer PatientsTerminatedNo Results AvailableProstate CancerDrug: leuprolide acetatehttps://ClinicalTrials.gov/show/NCT00630799
147546147546Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyCompletedHas ResultsColon Cancer|Colorectal Cancer|Rectal Cancer|Metastatic Colorectal Cancer|OncologyDrug: Panitumumab|Drug: Conatumumabhttps://ClinicalTrials.gov/show/NCT00630786
147547147547Q-CPR Compression Sensor Size Qualification in ChildrenCompletedNo Results AvailableCPRhttps://ClinicalTrials.gov/show/NCT00630773
147548147548Oral NRX 194204 in Patients With Refractory MalignanciesTerminatedNo Results AvailableRefractory MalignanciesDrug: NRX 194204https://ClinicalTrials.gov/show/NCT00630760
147549147549Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving IdursulfaseCompletedHas ResultsHunter Syndrome|Mucopolysaccharidosis II (MPS II)Biological: Idursulfasehttps://ClinicalTrials.gov/show/NCT00630747
147550147550Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and PravastatinCompletedHas ResultsHIV Infections|HyperlipidemiaDrug: Pravastatin|Drug: Darunavir|Drug: Ritonavir|Drug: Pravastatin|Other: Washouthttps://ClinicalTrials.gov/show/NCT00630734
147551147551Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic CellsCompletedNo Results AvailableMultiple SclerosisOther: IFNbeta-1bhttps://ClinicalTrials.gov/show/NCT00630721
147552147552Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal InsufficiencyRecruitingNo Results AvailableRenal Insufficiency, ChronicDrug: Benazepril|Drug: Losartan|Drug: Benazepril+Losartanhttps://ClinicalTrials.gov/show/NCT00630708
147553147553Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast CancerCompletedNo Results AvailableLymphoceleDrug: Lanreotide LP 90|Drug: Placebo lanreotidehttps://ClinicalTrials.gov/show/NCT00630695
147554147554A Pilot Trial of Dextroamphetamine for Methamphetamine DependenceCompletedNo Results AvailableMethamphetamine AddictionDrug: Dextroamphetamine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00630682
147555147555Comparison Between Two Endoscopic Treatments of Bleeding Internal Hemorrhoids:Band Ligation and Electrocoagulation ProbeCompletedNo Results AvailableHemorrhoidsProcedure: Rubber band ligation|Procedure: Bipolar coagulationhttps://ClinicalTrials.gov/show/NCT00630669
147556147556Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe SepsisCompletedNo Results AvailableSevere SepsisDrug: Talactoferrin alfa|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00630656
147557147557NI-0401 in Active Crohn's DiseaseCompletedNo Results AvailableModerate to Severe Crohn's DiseaseBiological: NI-0401 (anti-CD3 mAB)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00630643
147558147558Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial EpilepsyCompletedNo Results AvailableEpilepsyDrug: Levetiracetam|Other: Placebohttps://ClinicalTrials.gov/show/NCT00630630
147559147559Childhood Obesity PreventionCompletedNo Results AvailableChildhood Obesity|DiabetesBehavioral: Diet, Physical activity, Physical inactivityhttps://ClinicalTrials.gov/show/NCT00630617
147560147560Quantitative Ultrasonography (US) Evaluation on Femoral Condyle CartilageCompletedNo Results AvailableOsteoarthritishttps://ClinicalTrials.gov/show/NCT00630604
147561147561DAMES: Daughters And MothErS Against Breast CancerCompletedNo Results AvailableBreast CancerBehavioral: Standardized Materials Group|Behavioral: Independent Tailored Intervention|Behavioral: Partner-Assisted Tailored Interventionhttps://ClinicalTrials.gov/show/NCT00630591
147562147562Improving Effectiveness: Treatment Outcome ResearchCompletedNo Results AvailablePosttraumatic Stress DisorderBehavioral: Cognitive Processing Therapyhttps://ClinicalTrials.gov/show/NCT00630578
147563147563Stem Cell Transplant in Treating Patients With Acute Myeloid LeukemiaRecruitingNo Results AvailableLeukemiaBiological: sargramostim|Drug: busulfan|Drug: cyclophosphamide|Drug: dexamethasone|Drug: etoposide|Procedure: bone marrow transplantation|Procedure: hematopoietic stem cell transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: total-body irradiationhttps://ClinicalTrials.gov/show/NCT00630565
147564147564A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerCompletedNo Results AvailableAdenocarcinoma of the Pancreas|Metastatic Pancreatic Cancer|Pancreatic CancerOther: Placebo|Drug: AMG 479|Drug: AMG 655https://ClinicalTrials.gov/show/NCT00630552
147565147565A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal WomenCompletedHas ResultsAtrophy|Vaginal DiseasesDrug: Placebo|Drug: Ospemifene 5 mg|Drug: Ospemifene 15 mg|Drug: Ospemifene 30 mghttps://ClinicalTrials.gov/show/NCT00630539
147566147566[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00630526
147567147567T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- SulbactamCompletedNo Results AvailableIntra-Abdominal InfectionDrug: Ertapenem|Drug: Ampicillin-Sulbactamhttps://ClinicalTrials.gov/show/NCT00630513
147568147568Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)CompletedNo Results AvailableDementia Associated With Parkinson's Disease|Dementia With Lewy BodiesDrug: Memantine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00630500
147569147569Efficacy of Somatropin in Adult Patients With Isolated Growth Hormone DeficiencyTerminatedHas ResultsGrowth Hormone DeficiencyDrug: Placebo|Drug: Somatropinhttps://ClinicalTrials.gov/show/NCT00630487
147570147570Nasal Decongestion and Obstructive Sleep ApneaCompletedNo Results AvailableObstructive Sleep Apnea Syndrome|RhinitisDrug: xylometazolinehttps://ClinicalTrials.gov/show/NCT00630474

* Görseller ve İçerik tekif hakkına sahip olabilir